AdvaMed, the Medtech Association, today released the following statement from President and CEO Scott Whitaker following the imposition of tariffs on products from Canada, Mexico, and China:
Today, AdvaMed, the Medtech Association, released its “Patients First Agenda,” a series of state-level policies aimed at improving lives and patient outcomes through increasing access to medical technology, accurate diagnostic…
On the Medtech POV podcast , AdvaMed President and CEO Scott Whitaker sat down with Jacob “Jake” Leach, Executive Vice President and Chief Operating Officer at Dexcom, to discuss the…
On the Medtech POV podcast, AdvaMed President and CEO Scott Whitaker sat down with Martina Navratilova and Chris Evert, professional tennis legends who met as teen-age competitors and whose friendship…
AdvaMed, the Medtech Association, commended the House of Representatives’ bipartisan Task Force on Artificial Intelligence for urging the Centers for Medicare & Medicaid Services (CMS) to develop a formalized payment…
AdvaMed, the Medtech Association, asked the United States Court of Appeals to support a fair and balanced approach to patent damages.
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on President-elect Trump’s announcement that he intends to nominate Dr. Martin Makary to Lead FDA:
AdvaMed, the Medtech Association, recently published a technical white paper outlining concerns with third-party modification of interventional X-ray equipment, which can pose unforeseen risks for patients and providers.
AdvaMed, the Medtech Association, today welcomed introduction in the U.S. Senate of bipartisan legislation to expedite Medicare coverage of FDA-“breakthrough”-designated medical technologies and diagnostic tests. The legislation, the Ensuring Patient…
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on President-elect Trump’s announcement that he intends to nominate Dr. Mehmet Oz to serve as Administrator…